Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01720690
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
DCH![]() | 3-(7-DIAMINOMETHYL-NAPHTHALEN-2- YL)-PROPIONIC ACID ETHYL ESTER | H | 1UVU | 0.71 | ![]() |
ERT![]() | METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY- 7-METHOXY-6,11-DIOXO-4-{[2,3,6- TRIDEOXY-3-(DIMETHYLAMINO)-BETA- D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H- TETRACENE-1-CARBOXYLATE | A,B | 1TW2 | 0.75 | ![]() |
ERT![]() | METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY- 7-METHOXY-6,11-DIOXO-4-{[2,3,6- TRIDEOXY-3-(DIMETHYLAMINO)-BETA- D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H- TETRACENE-1-CARBOXYLATE | A,B | 1TW3 | 0.75 | ![]() |
S2A![]() | A | 2OEY | 0.74 | ![]() | |
AKT![]() | 10-DECARBOXYMETHYLACLACINOMYCIN T (DCMAT) | A | 1Q0R | 0.71 | ![]() |
SHP![]() | (4-HYDROXYMALTOSEPHENYL)GLYCINE | A | 1DSR | 0.71 | ![]() |
K55![]() | (2S)-2-{4-butoxy-3-[({[2-fluoro- 4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]benzyl}butanoic acid | A,B | 2ZNP | 0.72 | ![]() |
AP1![]() | {3-[3-(3,4-DIMETHOXY-PHENYL)-1- (1-{1-[2-(3,4,5-TRIMETHOXY-PHENYL)- BUTYRYL]-PIPERIDIN-2YL}-VINYLOXY)- PROPYL]-PHENOXY}-ACETIC ACID | A,B | 1BL4 | 0.75 | ![]() |
0EZ![]() | tert-butyl [(1S,2S)-1-benzyl-2- hydroxy-3-{[(8S,11R)-8-[(1R)-1- methylpropyl]-7,10-dioxo-2-oxa- 6,9-diazabicyclo[11.2.2]heptadeca- 1(15),13,16-trien-11-yl]amino}propyl]carbamate | A,B | 1MTR | 0.7 | ![]() |
TXL![]() | TAXOTERE | A,B,K | 1IA0 | 0.71 | ![]() |
TXL![]() | TAXOTERE | A,B | 1TUB | 0.71 | ![]() |
FLQ![]() | N-[6-(ACETYLAMINO)HEXYL]-3',6'- DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN- 1,9'-XANTHENE]-6-CARBOXAMIDE | C | 2FDC | 0.7 | ![]() |
HEH![]() | HEDAMYCIN | A | 1JHI | 0.73 | ![]() |
NGU![]() | U-58872, HYDROXY DERIVATIVE OF NOGALAMYCIN | A,B | 1D22 | 0.73 | ![]() |
NM1![]() | 3-(7-BENZYL-4,5-DIHYDROXY-1,1-DIOXO- 3,6-BIS-PHENOXYMETHYL-1L6-[1,2,7]THIADIAZEPAN- 2-YLMETHYL)-N-METHYL-BENZAMIDE | B | 1G2K | 0.71 | ![]() |
OBE![]() | 3-(3-HYDROXY-BENZOYLOXY)-8-METHYL- 8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID | H | 1RIV | 0.71 | ![]() |
4SR![]() | (4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN- 2-ONE | A,B | 1XN0 | 0.71 | ![]() |
ADF![]() | 4-{[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN- 1-YL]CARBONYL}PYRROLIDIN-2-YL]METHOXY}- 3-TERT-BUTYLBENZOIC ACID | A | 2G5P | 0.71 | ![]() |
CHR![]() | NEOCARZINOSTATIN-CHROMOPHORE | A | 1O5P | 0.7 | ![]() |
CHR![]() | NEOCARZINOSTATIN-CHROMOPHORE | A,B | 1NCO | 0.7 | ![]() |
XX6![]() | 2-{[(2R)-2-HYDROXY-3-(9-PHENANTHRYLOXY)PROPYL]AMINO}PROPANE- 1,3-DIOL | A | 2V3I | 0.7 | ![]() |
XX7![]() | 2-{[(2S)-2-HYDROXY-3-(9-PHENANTHRYLOXY)PROPYL]AMINO}PROPANE- 1,3-DIOL | A | 2V3R | 0.7 | ![]() |
VNL![]() | 4-HYDROXY-3-METHOXYBENZOATE | A,B,C,D | 2AHC | 0.7 | ![]() |
VNL![]() | 4-HYDROXY-3-METHOXYBENZOATE | A | 1XLR | 0.7 | ![]() |
ROL![]() | ROLIPRAM | A,B,C,D | 1OYN | 0.71 | ![]() |
ROL![]() | ROLIPRAM | A,B | 1XMY | 0.71 | ![]() |
ROL![]() | ROLIPRAM | A,B,C,D | 1Q9M | 0.71 | ![]() |
ROL![]() | ROLIPRAM | A,B | 1RO6 | 0.71 | ![]() |
ROL![]() | ROLIPRAM | A,B | 1XN0 | 0.71 | ![]() |
ROL![]() | ROLIPRAM | A,B | 1TBB | 0.71 | ![]() |
MNG![]() | MENOGARIL | A,B | 202D | 0.73 | ![]() |
C41![]() | ALISKIREN | C,O | 2V0Z | 0.74 | ![]() |
C61![]() | (2R,4S,5S,7S)-5-AMINO-N-BUTYL-4- HYDROXY-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]- 2,8-DIMETHYLNONANAMIDE | C,O | 2V10 | 0.75 | ![]() |
DBO![]() | N-{(1S,2R)-1-BENZYL-2-HYDROXY-3- [(3-METHYLBENZYL)AMINO]PROPYL}DIBENZO[B,F]OXEPINE- 10-CARBOXAMIDE | A,B,C,D | 2EWY | 0.72 | ![]() |
MUS![]() | 4-METHYL-2-OXO-2H-CHROMEN-7-YL 5- (ACETYLAMINO)-3,5-DIDEOXY-L-ERYTHRO- NON-2-ULOPYRANOSIDONIC ACID | A | 1S0J | 0.72 | ![]() |
2TN![]() | 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE | A | 2OTF | 0.74 | ![]() |
2TN![]() | 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE | A | 2NUV | 0.74 | ![]() |
2TN![]() | 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE | A | 2OUB | 0.74 | ![]() |
886![]() | N-({4'-[(4-isobutyrylphenoxy)methyl]biphenyl- 4-yl}sulfonyl)-D-valine | A,B,C,D | 2RJP | 0.71 | ![]() |
PH9![]() | (2Z)-2-[(1-ADAMANTYLCARBONYL)AMINO]- 3-[4-(2-BROMOPHENOXY)PHENYL]PROP- 2-ENOIC ACID | A | 1Z4U | 0.73 | ![]() |
BHP![]() | (S)-5-(4-BENZYLOXY-PHENYL)-4-(7- PHENYL-HEPTANOYLAMINO)-PENTANOIC ACID | A,B | 1J1A | 0.72 | ![]() |
NOD![]() | N-ETHYLHYDROXY-DOXORUBICIN | A | 385D | 0.76 | ![]() |
TBH![]() | 5-(2-{2-[(TERT-BUTOXY-HYDROXY-METHYL)- AMINO]-1-HYDROXY-3-PHENYL-PROPYLAMINO}- 3-HYDROXY-3-PENTYLAMINO-PROPYL)- 2-CARBOXYMETHOXY-BENZOIC ACID | B | 1JF7 | 0.72 | ![]() |
B8L![]() | 3-[(3-SEC-BUTYL-4-HYDROXYBENZOYL)AMINO]AZEPAN- 4-YL 4-(2-HYDROXY-5-METHOXYBENZOYL)BENZOATE | A | 1REK | 0.71 | ![]() |
L01![]() | 3-[({(1S,2R)-1-BENZYL-2-HYDROXY- 3-[(3-METHOXYBENZYL)AMINO]PROPYL}AMINO)(HYDROXY)METHYL]- N,N-DIPROPYLBENZAMIDE | A | 1W51 | 0.71 | ![]() |
NCS![]() | B | 1KVH | 0.72 | ![]() | |
NCS![]() | A | 2NEO | 0.72 | ![]() | |
B1L![]() | 3-[(4-HYDROXYBENZOYL)AMINO]AZEPAN- 4-YL 4-HYDROXYBENZOATE | A | 1REJ | 0.7 | ![]() |
NN4![]() | (1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)- 2-METHYLPROPANOYL]AMINO}ADAMANTANE- 1-CARBOXAMIDE | A,B,C,D,E,F, G,H | 2IRW | 0.72 | ![]() |
DM1![]() | DAUNOMYCIN | A | 152D | 0.73 | ![]() |
DM1![]() | DAUNOMYCIN | A,B,C,D | 1O0K | 0.73 | ![]() |
DM1![]() | DAUNOMYCIN | A | 1JO2 | 0.73 | ![]() |
DM1![]() | DAUNOMYCIN | A,B | 308D | 0.73 | ![]() |
DM1![]() | DAUNOMYCIN | A | 1D33 | 0.73 | ![]() |
DM1![]() | DAUNOMYCIN | A | 110D | 0.73 | ![]() |
DM1![]() | DAUNOMYCIN | A | 1D11 | 0.73 | ![]() |
DM1![]() | DAUNOMYCIN | A | 427D | 0.73 | ![]() |
DM1![]() | DAUNOMYCIN | A | 2D34 | 0.73 | ![]() |
DM1![]() | DAUNOMYCIN | A | 3F8F | 0.73 | ![]() |
DM1![]() | DAUNOMYCIN | A | 1D10 | 0.73 | ![]() |
DM1![]() | DAUNOMYCIN | A | 1DA0 | 0.73 | ![]() |
C39![]() | N-[(2S,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-7-METHYL-2-(1-METHYLETHYL)- 8-OXOOCTYL]-2-(3-METHOXYPROPOXY)BENZAMIDE | C,O | 2V12 | 0.71 | ![]() |
Y12![]() | 4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP- 1-EN-1-YL}-1,2-PHENYLENE DIACETATE | A | 2EW5 | 0.72 | ![]() |
DM5![]() | IDARUBICIN | A,B,D | 198D | 0.7 | ![]() |
DM5![]() | IDARUBICIN | A | 1D38 | 0.7 | ![]() |
DM5![]() | IDARUBICIN | A | 1D67 | 0.7 | ![]() |
VXX![]() | VANILLATE | A,B | 1WB6 | 0.71 | ![]() |
BDA![]() | 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] | A | 1AL9 | 0.73 | ![]() |
BDA![]() | 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] | A | 1AGL | 0.73 | ![]() |
AKY![]() | A,B,C,D | 2IPI | 0.7 | ![]() | |
DM3![]() | 6-DEOXYDAUNOMYCIN | A | 1D14 | 0.73 | ![]() |
DM2![]() | DOXORUBICIN | A | 2DR6 | 0.73 | ![]() |
DM2![]() | DOXORUBICIN | A | 1P20 | 0.73 | ![]() |
DM2![]() | DOXORUBICIN | A | 1I1E | 0.73 | ![]() |
DM2![]() | DOXORUBICIN | A | 151D | 0.73 | ![]() |
DM2![]() | DOXORUBICIN | A | 1D12 | 0.73 | ![]() |
DM2![]() | DOXORUBICIN | A | 1DA9 | 0.73 | ![]() |
DM6![]() | 4'-EPIDOXORUBICIN | A | 1D15 | 0.73 | ![]() |
DM6![]() | 4'-EPIDOXORUBICIN | A | 1D54 | 0.73 | ![]() |
DM6![]() | 4'-EPIDOXORUBICIN | A | 1D58 | 0.73 | ![]() |
DM6![]() | 4'-EPIDOXORUBICIN | A | 1QDA | 0.73 | ![]() |
TMS![]() | N-PROPYL-4-[(E)-2-(3,4,5-TRIMETHOXY- PHENYL)-VINYL]-BENZAMIDE | A,B | 1X6W | 0.74 | ![]() |
HWG![]() | N-(TERT-BUTYL)-3,5-DIMETHYL-N'- [(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN- 6-YL)CARBONYL]BENZOHYDRAZIDE | A,D | 1R20 | 0.7 | ![]() |
AI1![]() | N-BENZYL-3-(ALPHA-D-GALACTOS-1- YL)-BENZAMIDE | D,E,F,G,H,L, M,N,O,P | 1FD7 | 0.74 | ![]() |
NGM![]() | NOGALAMYCIN | A,B,C,D | 258D | 0.73 | ![]() |
NGM![]() | NOGALAMYCIN | A | 282D | 0.73 | ![]() |
NGM![]() | NOGALAMYCIN | A,B | 224D | 0.73 | ![]() |
NGM![]() | NOGALAMYCIN | A,B | 245D | 0.73 | ![]() |
NGM![]() | NOGALAMYCIN | A,B | 1QCH | 0.73 | ![]() |
NGM![]() | NOGALAMYCIN | A | 1D17 | 0.73 | ![]() |
NGM![]() | NOGALAMYCIN | A,B | 1D21 | 0.73 | ![]() |
NGM![]() | NOGALAMYCIN | A,B | 182D | 0.73 | ![]() |
AB8![]() | (1S,3R,8AS)-8-(2-{(4S,6S)-3-(4- HYDROXY-3-METHOXYBENZYL)-4-[2-(METHYLAMINO)- 2-OXOETHYL]-2-OXO-1,3-OXAZINAN- 6-YL}ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A- HEXAHYDRONAPHTHALEN-1-YL (2R)-2- METHYLBUTANOATE | A,B | 1XDG | 0.71 | ![]() |
DRS![]() | (9S,12S)-9-(1-methylethyl)-7,10- dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca- 1(16),14,17-triene-12-carboxylic acid | A,B | 3BXS | 0.71 | ![]() |
NGP![]() | NOGALAMYCIN (PROTONATED FORM) | A | 1L0R | 0.74 | ![]() |
TA1![]() | TAXOL | A,B | 1JFF | 0.72 | ![]() |
TA1![]() | TAXOL | A,B,C | 2HXH | 0.72 | ![]() |
TA1![]() | TAXOL | A,B,N | 3DCO | 0.72 | ![]() |
TA1![]() | TAXOL | A,B,K | 2P4N | 0.72 | ![]() |
TA1![]() | TAXOL | A,B,D,F,G | 3EDL | 0.72 | ![]() |
TA1![]() | TAXOL | A,B,C | 2HXF | 0.72 | ![]() |
TA1![]() | TAXOL | A,B,C | 2WBE | 0.72 | ![]() |
EH5![]() | N-(1-BENZYL-3-{[3-(1,3-DIOXO-1,3- DIHYDRO-ISOINDOL-2-YL)-PROPIONYL]- [2-(HEXAHYDRO-BENZO[1,3]DIOXOL- 5-YL)-ETHYL]-AMINO}-2-HYDROXY-PROPYL)- 4-BENZYLOXY-3,5-DIMETHOXY-BENZAMIDE | A | 1LF3 | 0.73 | ![]() |
ANM![]() | ANISOMYCIN | 1,2,4,A,B,C, D,E,J,K,L,M, N,O,P,R,S,T, U,V,Z | 1K73 | 0.73 | ![]() |
ANM![]() | ANISOMYCIN | 0,1,3,9,A,B, C,F,H,J,K,L, M,N,O,Q,R,S, T,U,Y,Z | 3CC4 | 0.73 | ![]() |
429![]() | 2-{4-[2-ACETYLAMINO-3-(4-CARBOXYMETHOXY- 3-HYDROXY-PHENYL)-PROPIONYLAMINO]- BUTOXY}-6-HYDROXY-BENZOIC ACID METHYL ESTER | A | 1QXK | 0.72 | ![]() |
E20![]() | 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON- 2-YL)METHYL]PIPERIDINE | A | 1EVE | 0.71 | ![]() |
S44![]() | (2S)-2-(4-propoxy-3-{[({4-[(3S,5S,7S)- tricyclo[3.3.1.1~3,7~]dec-1-yl]phenyl}carbonyl)amino]methyl}benzyl)butanoic acid | A | 2ZNN | 0.77 | ![]() |
S44![]() | (2S)-2-(4-propoxy-3-{[({4-[(3S,5S,7S)- tricyclo[3.3.1.1~3,7~]dec-1-yl]phenyl}carbonyl)amino]methyl}benzyl)butanoic acid | A,B | 2ZNO | 0.77 | ![]() |
DMM![]() | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A | 215D | 0.71 | ![]() |
DMM![]() | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A | 235D | 0.71 | ![]() |
DMM![]() | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A | 234D | 0.71 | ![]() |
DMM![]() | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A,B | 2DES | 0.71 | ![]() |
PI6![]() | [1-BENZYL-3-(8-SEC-BUTYL-7,10-DIOXO- 2-OXA-6,9-DIAZA-BICYCLO[11.2.2] HEPTADECA- 1(16),13(17),14-TRIEN-11-YLAMINO)- 2-HYDROXY-PROPYL] -CARBAMIC ACID TERT- BUTYL ESTER | A,B | 1B6M | 0.7 | ![]() |
DM4![]() | 1-O-DEMETHYL-6-DEOXYDOXORUBICIN | A | 1D37 | 0.71 | ![]() |
DM8![]() | 2'-BROMO-4'-EPIDAUNORUBICIN | A | 276D | 0.71 | ![]() |
DM8![]() | 2'-BROMO-4'-EPIDAUNORUBICIN | A | 288D | 0.71 | ![]() |
DM8![]() | 2'-BROMO-4'-EPIDAUNORUBICIN | A | 277D | 0.71 | ![]() |
DM8![]() | 2'-BROMO-4'-EPIDAUNORUBICIN | A,B | 380D | 0.71 | ![]() |
DM8![]() | 2'-BROMO-4'-EPIDAUNORUBICIN | A,B | 381D | 0.71 | ![]() |
DM8![]() | 2'-BROMO-4'-EPIDAUNORUBICIN | A | 278D | 0.71 | ![]() |
MAR![]() | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1D36 | 0.72 | ![]() |
MAR![]() | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1R68 | 0.72 | ![]() |
MAR![]() | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1D35 | 0.72 | ![]() |
C40![]() | N-[(2R,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-2,7-DIMETHYL-8-OXOOCTYL]- 2-(3-METHOXYPROPOXY)BENZAMIDE | A | 2V13 | 0.7 | ![]() |
BNR![]() | BIS-DAUNORUBICIN | B | 1AMD | 0.7 | ![]() |
INX![]() | 2-(CARBOXYMETHOXY)-5-[(2S)-2-({(2S)- 2-[(3-CARBOXYPROPANOYL)AMINO] - 3-PHENYLPROPANOYL}AMINO)-3-OXO- 3-(PENTYLAMINO)PROPYL]BENZOIC ACID | A | 1G7G | 0.7 | ![]() |